NeuroPace, Inc. (NPCE) Profit Margins
Over the twelve months to 2026-06-30, NeuroPace, Inc. (NPCE) had gross margin 79.6%, operating margin -15.3%, net margin -19.3%, free cash flow margin -11.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NPCENeuroPace, Inc.Follow NPCE — free
—
Price chart with a free account
- Market cap
- 443.1M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 74.0% | 71.4% | 73.6% | 73.9% | 77.2% | 79.6% | |
| Operating margin | -52.5% | -89.6% | -41.5% | -27.1% | -16.3% | -15.3% | |
| Net margin | -79.9% | -103.4% | -50.4% | -34.0% | -21.5% | -19.3% | |
| FCF margin | -55.2% | -82.3% | -30.4% | -22.8% | -11.3% | -11.7% |
USD millions · SEC XBRL
NeuroPace, Inc. — questions
- What is NeuroPace, Inc.'s gross margin?
- 79.6% over the twelve months to 2026-06-30.
- What is NeuroPace, Inc.'s operating margin?
- -15.3% over the twelve months to 2026-06-30.
- What is NeuroPace, Inc.'s net profit margin?
- -19.3% over the twelve months to 2026-06-30.
Every figure on this page comes from NeuroPace, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.